10-Q: Ardent Health Partners Reports Q1 2025 Results: Revenue Up 4% Driven by Volume Growth
Quarterly Report
Ardent Health Partners' Q1 2025 revenue increased by 4% year-over-year, driven by a rise in adjusted admissions and net patient service revenue per adjusted admission.
Summary
- Ardent Health Partners reported a 4.0% increase in total revenue for Q1 2025, reaching $1,497.234 million compared to $1,439.046 million in Q1 2024.
- The revenue increase was driven by a 2.7% rise in adjusted admissions and a 1.2% increase in net patient service revenue per adjusted admission.
- Adjusted admissions grew due to a 7.6% increase in admissions and a 2.3% increase in emergency room visits, partially offset by a 0.7% decrease in total surgeries.
- Net income attributable to Ardent Health Partners, Inc. increased to $41.383 million, or $0.30 per basic share, compared to $27.047 million, or $0.21 per basic share, in the prior year.
- Operating expenses increased to $1,423.036 million, but decreased as a percentage of total revenue to 95.0% from 96.1% in the prior year.
- The company recognized $21.5 million in insurance recovery proceeds related to a cybersecurity incident, contributing to other non-operating gains.
- The effective tax rate was 20.5% for Q1 2025, compared to 18.9% for Q1 2024.
- Adjusted EBITDA increased to $98.201 million from $95.814 million in the prior year.
- The company completed the acquisition of certain assets and operations of 18 urgent care clinics in New Mexico and Oklahoma on January 1, 2025, for $27.5 million.
Sentiment
Score: 7
Explanation: The document presents a generally positive outlook with revenue growth and increased profitability, but also acknowledges ongoing challenges and risks.
Positives
- Revenue growth driven by increased patient volume and improved revenue per adjusted admission.
- Recognition of insurance recovery proceeds related to the cybersecurity incident positively impacted the bottom line.
- Successful acquisition of urgent care clinics expands the company's footprint.
- The company's net leverage ratio was 1.4x and lease-adjusted net leverage ratio was 3.0x as of March 31, 2025.
- Adjusted EBITDA increased to $98.201 million.
Negatives
- Operating cash flow decreased compared to the prior year due to changes in working capital.
- Professional fees increased as a percentage of total revenue due to higher costs for hospital-based providers.
- Salaries and benefits increased as a percentage of total revenue due to an increase in equity-based compensation.
Risks
- The company's operations are dependent on the efforts, abilities and experience of its management and medical support personnel, such as nurses, pharmacists and lab technicians, as well as its physicians.
- The company is subject to market risk from exposure to changes in interest rates based on its financing, investing and cash management activities.
- The company's facilities are heavily concentrated in Texas and Oklahoma, which makes it sensitive to regulatory, economic and competitive conditions and changes in those states.
- The company is subject to possible reductions or other changes in Medicare, Medicaid and other state programs, including Medicaid supplemental payment programs, Medicaid waiver programs or state directed payments, that could have an adverse effect on its revenues and business.
Future Outlook
The company believes the combination of cash flow from operations and available cash and borrowings will be adequate to meet its short-term liquidity needs.
Industry Context
The healthcare industry is experiencing trends such as a growing focus on healthcare spending, a shift to outpatient settings, an aging population, and ongoing consolidation of providers and insurers.
Comparison to Industry Standards
- The document does not provide enough information to make a detailed comparison to industry standards.
- To compare Ardent Health Partners to industry standards, we would need to benchmark against comparable companies such as HCA Healthcare, Tenet Healthcare, and Community Health Systems.
- Key metrics for comparison would include revenue growth, EBITDA margins, debt levels, and occupancy rates.
- Additionally, comparing Ardent's performance in specific markets (Texas, Oklahoma, New Mexico, New Jersey) to regional and national averages would provide valuable insights.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Operating Officer | Dave Caspers | 2025-04-01 | New Hire |
Legal Proceedings
- Three putative class actions were filed against the Company in the U.S. District Court for the Middle District of Tennessee related to the Cybersecurity Incident.
- The Company executed a settlement agreement to resolve the consolidated class action litigation.
- Settlement of the consolidated case on the agreed terms will require the Company to make cash settlement payments that will not have a material impact on the Company’s results of operations, financial position or liquidity.
Related Party Transactions
- The company recorded rent expense related to the Ventas Master Lease and other lease agreements with Ventas for certain medical office buildings of $38.1 million and $37.2 million f or the three months ended March 31, 2025 and 2024 , respectively.
Stakeholder Impact
- The company provides care without charge to certain patients who qualify under the local charity care policy of the hospital where the patient receives services.
- The company estimates that its costs of care provided under its charity care programs approximated $8.2 million and $19.7 million for the three months ended March 31, 2025 and 2024 , respectively.
Key Dates
| Date | Description |
|---|---|
| 2015-08-04 | Ventas acquired ownership of the Company’s real estate in exchange for a $1.4 billion payment from Ventas and the Company’s agreement to lease the acquired real estate back from Ventas (the Ventas Master Lease). |
| 2021-07-08 | AHP Health Partners issued the 5.75% Senior Notes due 2029. |
| 2021-08-24 | The Company entered into a credit agreement for its senior secured term loan facility. |
| 2023-11-03 | The Company determined that a ransomware cybersecurity incident had impacted and disrupted a number of the Company’s operational and information technology systems. |
| 2024-07-17 | Ardent Health Partners, LLC converted from a Delaware limited liability company into a Delaware corporation in connection with its initial public offering and changed its name to Ardent Health Partners, Inc. |
| 2024-07-19 | The Company completed an initial public offering of 12,000,000 shares of its common stock at a public offering price of $16.00 per share. |
| 2024-07-30 | The Company issued 1,800,000 additional shares of common stock at $16.00 per share after the underwriters fully exercised their option. |
| 2024-09-18 | The Company executed an amendment to reprice its Term Loan B Credit Agreement. |
| 2025-01-01 | The Company completed the acquisitions of certain assets and operations of 18 urgent care clinics in New Mexico and Oklahoma for a combined purchase price of $27.5 million. |
| 2025-03-31 | End of the quarterly period. |
| 2025-04-01 | Anticipated start date for Dave Caspers as Chief Operating Officer. |
| 2025-08-01 | Hearing for the District Courts final approval of the settlement for the consolidated class action litigation. |
Keywords
revenue, adjusted admissions, EBITDA, acquisitions, healthcare, hospitals, financial results, Ardent Health Partners
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.